Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
ACM, aerospace, Alpha, Anstalt, attorney, automated, automation, Ayer, Bain, Baltimore, banker, Beta, BIF, Biochemical, biotech, bore, BRAF, bridge, Brookside, Burbank, check, combat, Commissioner, contemplated, County, coupled, cum, delinquent, diagnosed, die, died, disseminated, dollar, Duska, estate, evidenced, explanatory, extinguish, extinguished, fewer, fill, Floor, footnote, forbearing, foreclosed, forty, fullest, fundraising, Galena, GenCorp, Hillsberg, immunocellular, incorprated, Indian, inhibitor, ipilimumab, Jay, Kappa, Kestrel, laude, licensee, lien, lieu, Lion, loan, LP, magna, Manish, Matrix, McKinsey, Medco, men, Mine, Navex, NIC, notwithstanding, opt, pari, partially, passu, Patricof, PC, persist, Phi, physical, PI, PIPE, pledge, potency, predecessor, proforma, ratio, reconstitute, renew, rental, Repricing, restyled, reuse, robust, Roorkee, Sanford, sentence, settle, simplify, Singh, TroyGould, unamortized, unclear, underwent, unpaid, upcoming, vacancy, Varro, vemurafenib, Venkatesan, Venkatesen, Wharton, women, Woodland, Worcester
Removed:
Abotaleb, accelerated, added, ahn, AICPA, Anshuman, antigen, assessed, brooke, closed, commensurate, communication, composed, computing, conducting, consolidated, correspondingly, CRT, deferred, directed, dispositive, distribute, Dube, earliest, enactment, England, entering, establishment, ethical, fatal, flow, forward, furnish, Gerald, government, Ibrahim, intelligent, investigating, lethal, Licence, mark, mckilligan, monitoring, online, outsource, principally, qualification, realized, recognition, refusal, register, registering, rent, retroactively, richard, robert, temporary, treasurer, underserved
Filing tables
Filing exhibits
IOVA similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, I, Manish Singh, Chief Executive Officer of Genesis Biopharma, Inc. (the “Company”), hereby certify that, to the best of my knowledge:
(i) the Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2012 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
| Date: September 23, 2013 | By: | /s/ MANISH SINGH | |
| Name: Manish Singh | |||
| Title: Chief Executive Officer (Principal Executive Officer) | |||